Akso Health Group (AHG)
NASDAQ: AHG
· Real-Time Price · USD
1.80
0.06 (3.45%)
At close: Aug 15, 2025, 3:19 PM
1.80
-0.12%
After-hours: Aug 15, 2025, 04:04 PM EDT
Akso Health Income Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Revenue | 2.41M | 2.32M | 2.22M | 7.7M | 13.18M | 15.24M | 17.61M | 11.81M | 6M | 1.72M | -1.11M | -553.65K | n/a | 2.43M | 3.11M | 6.97M |
Cost of Revenue | 2.29M | 2.16M | 2.04M | 6.97M | 11.91M | 11.5M | 10.91M | 6.39M | 1.02M | 6.61M | 13.05M | 13.67M | 20.11M | 14.44M | 8.1M | 8.87M |
Gross Profit | 122.13K | 152.04K | 181.94K | 725.47K | 1.27M | 6,311.1B | 6,311.1B | 6,311.1B | 6,311.1B | -15.06M | -24.34M | -23.84M | -29.73M | 107.23B | 107.23B | 107.24B |
Operating Income | -8.64M | -12.5M | -16.36M | -15.31M | -14.27M | 13.15M | 16.54M | 7.73M | 3.91M | -27M | -29.2M | -43.87M | -47.68M | 75.86B | 75.86B | 75.87B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 102.07K | 402.07K | 702.07K | 702.07K | 1.1M | 1.38M | 1.66M | 1.66M | 1.78M | 1.2M |
Pretax Income | -9.09M | -13.43M | -17.76M | -15.42M | -13.07M | 12.63M | 16.08M | 15.25M | 9.97M | -21.1M | -24M | -24M | -28.27M | 76.54B | 76.52B | 76.51B |
Net Income | -9.06M | -13.48M | -17.89M | -15.54M | -13.2M | 8.93M | 12.37M | 28.45M | 23.18M | -11.65M | -14.7M | -15.29M | -19.59M | 65.53B | 65.51B | 65.48B |
Selling & General & Admin | 8.76M | 12.65M | 16.54M | 16.04M | 15.54M | 14.95M | 9.3M | 12.69M | 16.07M | 10.92M | 21.94M | 19.86M | 17.78M | 21.05B | 21.04B | 21.05B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | 14.7K | 127.35K | 240K | 460.7K | 666.7K | 554.05K | 441.41K | 279.67K | 117.94K | 117.94K |
Other Expenses | -3.4 | -13.86 | -13.86 | -10.4 | -10.4 | -1.22 | -1.22 | -37.47 | -37.47 | 4.35M | 4.35M | 4.35M | 4.35M | -12.89 | -12.89 | n/a |
Operating Expenses | 9.35M | 13.58M | 17.95M | 16.67M | 15.4M | -18.99M | -24.8M | -20.79M | -16.78M | 15.88M | 27.21M | 25.31M | 23.42M | 21.05B | 21.06B | 21.07B |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 643.2K |
Selling & Marketing Expenses | 168.42K | 131.01K | 93.59K | 143.72K | 193.85K | 676.38K | 671.89K | 699.92K | 727.96K | 1.02M | 1.24M | 1.44M | 1.64M | 1.07M | 1.05M | 10.04M |
Cost & Expenses | 11.64M | 15.74M | 19.98M | 23.65M | 27.31M | -1.89M | -8.29M | -9.65M | -11.01M | 21.65M | 39.42M | 43.96M | 48.51M | 31.39B | 31.39B | 31.4B |
Income Tax Expense | 24.99K | 27.83K | 30.67K | 24.11K | 17.55K | 3.64M | 3.69M | 3.68M | 3.69M | 4.17M | 4.32M | 4.32M | 4.35M | 11.03B | 11.03B | 11.03B |
Shares Outstanding (Basic) | 20.81M | 20.79M | 7.62M | 7.62M | 7.42M | 7.42M | 8.25M | 8.25M | 6.62M | 6.06M | 5.5M | 5.5M | 5.43M | 5.42M | 5.43M | 5.43M |
Shares Outstanding (Diluted) | 23.83M | 23.83M | 7.62M | 7.62M | 7.62M | 7.62M | 7.62M | 7.62M | 6.62M | 6.13M | 5.63M | 5.63M | 5.43M | 5.42M | 5.43M | 5.43M |
EPS (Basic) | -0.69 | -1.53 | -2.37 | -2.07 | -1.77 | 1.44 | 1.77 | 4.71 | 3.81 | -2.13 | -2.76 | -2.82 | -3.63 | 13.11K | 13.11K | 13.1K |
EPS (Diluted) | -0.66 | -1.5 | -2.31 | -2.01 | -1.71 | 1.47 | 1.77 | 4.68 | 3.78 | -2.16 | -2.79 | -2.79 | -3.63 | 12.38K | 12.37K | 12.37K |
EBITDA | n/a | -7.02M | -14.04M | -14.14M | -14.24M | 1.83M | 5.22M | 1.39M | -2.44M | 7.74M | 5.56M | 1.9M | -1.76M | -29.54M | -32.31M | -34.26M |
EBIT | -8.64M | -12.5M | -16.36M | -15.31M | -14.27M | 1.8M | 5.19M | 1.37M | -2.46M | 7.73M | 5.52M | 1.72M | -2.09M | -29.89M | -32.64M | -33.7M |
Depreciation & Amortization | 8.64M | 5.48M | 2.33M | 1.18M | 25.35K | -7.74M | -7.74M | -16.65M | -16.65M | -22.07M | -22.04M | -30.58M | -30.44M | -17.23M | -17.26M | 281.26K |